5944 related articles for article (PubMed ID: 3397990)
1. Benzothiopyranoindazoles, a new class of chromophore modified anthracenedione anticancer agents. Synthesis and activity against murine leukemias.
Showalter HD; Angelo MM; Berman EM; Kanter GD; Ortwine DF; Ross-Kesten SG; Sercel AD; Turner WR; Werbel LM; Worth DF
J Med Chem; 1988 Aug; 31(8):1527-39. PubMed ID: 3397990
[TBL] [Abstract][Full Text] [Related]
2. Anthrapyrazole anticancer agents. Synthesis and structure-activity relationships against murine leukemias.
Showalter HD; Johnson JL; Hoftiezer JM; Turner WR; Werbel LM; Leopold WR; Shillis JL; Jackson RC; Elslager EF
J Med Chem; 1987 Jan; 30(1):121-31. PubMed ID: 3806589
[TBL] [Abstract][Full Text] [Related]
3. Chromophore-modified antineoplastic imidazoacridinones. Synthesis and activity against murine leukemias.
Cholody WM; Martelli S; Konopa J
J Med Chem; 1992 Jan; 35(2):378-82. PubMed ID: 1732555
[TBL] [Abstract][Full Text] [Related]
4. 6-[(aminoalkyl)amino]-substituted 7H-benzo[e]perimidin-7-ones as novel antineoplastic agents. Synthesis and biological evaluation.
Stefańska B; Dzieduszycka M; Martelli S; Tarasiuk J; Bontemps-Gracz M; Borowski E
J Med Chem; 1993 Jan; 36(1):38-41. PubMed ID: 8421288
[TBL] [Abstract][Full Text] [Related]
5. 2-(aminoalkyl)-5-nitropyrazolo[3,4,5-kl]acridines, a new class of anticancer agents.
Capps DB; Dunbar J; Kesten SR; Shillis J; Werbel LM; Plowman J; Ward DL
J Med Chem; 1992 Dec; 35(26):4770-8. PubMed ID: 1479579
[TBL] [Abstract][Full Text] [Related]
6. [The synthesis and biologic activity of analogs of 1,4-benzoquinone-guanylhydrazone-thiosemicarbazone. 2. Substitution at the quinone ring by alkyl groups].
Schulze W; Gutsche W; Wohlrabe K; Tresselt D; Horn G; Fleck W
Pharmazie; 1986 Feb; 41(2):99-101. PubMed ID: 3725863
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and anticancer activity of various 3'-deoxy pyrimidine nucleoside analogues and crystal structure of 1-(3-deoxy-beta-D-threo-pentofuranosyl)cytosine.
Lin TS; Yang JH; Liu MC; Shen ZY; Cheng YC; Prusoff WH; Birnbaum GI; Giziewicz J; Ghazzouli I; Brankovan V
J Med Chem; 1991 Feb; 34(2):693-701. PubMed ID: 1995894
[TBL] [Abstract][Full Text] [Related]
8. Bbr 2778, an aza-anthracenedione endowed with preclinical anticancer activity and lack of delayed cardiotoxicity.
Beggiolin G; Crippa L; Menta E; Manzotti C; Cavalletti E; Pezzoni G; Torriani D; Randisi E; Cavagnoli R; Sala F; Giuliani FC; Spinelli S
Tumori; 2001; 87(6):407-16. PubMed ID: 11989596
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitumor evaluation of 2,5-disubstituted-indazolo[4, 3-gh]isoquinolin-6(2H)-ones (9-aza-anthrapyrazoles).
Krapcho AP; Menta E; Oliva A; Di Domenico R; Fiocchi L; Maresch ME; Gallagher CE; Hacker MP; Beggiolin G; Giuliani FC; Pezzoni G; Spinelli S
J Med Chem; 1998 Dec; 41(27):5429-44. PubMed ID: 9876113
[TBL] [Abstract][Full Text] [Related]
10. Anthrapyrazoles, a new class of intercalating agents with high-level, broad spectrum activity against murine tumors.
Leopold WR; Nelson JM; Plowman J; Jackson RC
Cancer Res; 1985 Nov; 45(11 Pt 1):5532-9. PubMed ID: 4053027
[TBL] [Abstract][Full Text] [Related]
11. In vivo and in vitro anticancer activity of the structurally novel and highly potent antibiotic CI-940 and its hydroxy analog (PD 114,721).
Roberts BJ; Hamelehle KL; Sebolt JS; Leopold WR
Cancer Chemother Pharmacol; 1986; 16(2):95-101. PubMed ID: 3081269
[TBL] [Abstract][Full Text] [Related]
12. New anticancer agents: synthesis of 1,2-dihydropyrido[3,4-b]pyrazines (1-deaza-7,8-dihydropteridines).
Temple C; Wheeler GP; Elliott RD; Rose JD; Kussner CL; Comber RN; Montgomery JA
J Med Chem; 1982 Sep; 25(9):1045-50. PubMed ID: 7131483
[TBL] [Abstract][Full Text] [Related]
13. Biochemical pharmacology and DNA-drug interactions by Cl-958, a new antitumor intercalator derived from a series of substituted 2H-[1]benzothiopyrano[4,3,2-cd]indazoles.
Fry DW; Besserer JA
Mol Pharmacol; 1988 Jan; 33(1):84-92. PubMed ID: 2447481
[TBL] [Abstract][Full Text] [Related]
14. Design, biochemical pharmacology, electrochemistry and tumour biology of anti-tumour anthrapyrazoles.
Showalter HD; Fry DW; Leopold WR; Lown JW; Plambeck JA; Reszka K
Anticancer Drug Des; 1986 Apr; 1(2):73-85. PubMed ID: 2453196
[TBL] [Abstract][Full Text] [Related]
15. In vivo antitumor activity of 6-benzyl-1,3-benzodioxole derivatives against the P388, L1210, B16, and M5076 murine models.
Jurd L; Narayanan VL; Paull KD
J Med Chem; 1987 Oct; 30(10):1752-6. PubMed ID: 2821258
[TBL] [Abstract][Full Text] [Related]
16. Antineoplastic activity of didemnin congeners: nordidemnin and modified chain analogues.
Jouin P; Poncet J; Dufour MN; Aumelas A; Pantaloni A; Cros S; François G
J Med Chem; 1991 Feb; 34(2):486-91. PubMed ID: 1995869
[TBL] [Abstract][Full Text] [Related]
17. [N-quaternary derivatives of tilorone].
Schulze W; Letsch G; Gutsche W; Wohlrabe K; Tresselt D
Pharmazie; 1984 May; 39(5):320-2. PubMed ID: 6473490
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and cytotoxic activity of pyridylthio, pyridylsulfinyl, and pyridylsulfonyl methyl acrylates.
Phillips OA; Nelson LA; Knaus EE; Allen TM; Fathi-Afshar R
Drug Des Deliv; 1989 Mar; 4(2):121-7. PubMed ID: 2765104
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, peroxidating ability, and antineoplastic evaluation of 1-[(aminoalkyl)amino]-4-hydroxy-10-imino-9-anthracenones.
Dzieduszycka M; Martelli S; Tarasiuk J; Paradziej-Lukowicz J; Borowski E
J Med Chem; 1991 Feb; 34(2):541-6. PubMed ID: 1995874
[TBL] [Abstract][Full Text] [Related]
20. 6,9-Bis[(aminoalkyl)amino]benzo[g]isoquinoline-5,10-diones. A novel class of chromophore-modified antitumor anthracene-9,10-diones: synthesis and antitumor evaluations.
Krapcho AP; Petry ME; Getahun Z; Landi JJ; Stallman J; Polsenberg JF; Gallagher CE; Maresch MJ; Hacker MP; Giuliani FC
J Med Chem; 1994 Mar; 37(6):828-37. PubMed ID: 8145234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
